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(57) ABSTRACT 
A method of producing a carotenoid in solid form includes 
culturing a strain of Chlorophyta algae cells in a minimal 
inorganic medium and separating the algae comprising a 
solid form of carotenoid. In one embodiment f the invention, 
the strain of Chlorophyta algae cells includes a strain f 
Chlamydomonas algae cells. 
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METHOD OF PRODUCING PURIFIED 
CAROTENOID COMPOUNDS 
This application is a 371 of PCTlUS00135503 Dec. 28, 
2000 which is a CON of No. 601175,187 Jan. 10, 2000. 
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FIELD OF INVENTION 
The invention relates to methods for preparing caro- 
tenoids, and in particular, to the production of carotenoids 
using various strains of algae. 
BACKGROUND OF THE INVENTION 
It is now generally recognized in medical circles that 
antioxidants play an important role in nutrition and in the 
prevention of certain diseases, such as macular degeneration 
of the eye. Accordingly, it is now routinely recommended 
that individuals consume a “recommended daily allowance” 
of antioxidants to maintain good health. 
Among the important antioxidants are the carotenoids, of 
which the most commonly known is beta-carotene. Other 
common carotenoids are the oxygenated form of beta- 
carotene, known as lutein, and another oxygenated caro- 
tenoid found in relatively low amounts in green plants and 
algae, zeaxanthin. 
While the carotenoids are known to have important health 
effects, these compounds are currently manufactured by 
expensive processes requiring extraction of the compounds 
from a natural source, and subsequent purification. As a 
result, for example, lutein, which is an abundant plant and 
algal carotenoid, is currently sold for about $50,000 per 
gram. Zeaxanthin, produced from certain cyanobacteria, has 
a market price of approximately $100,000 per gram. These 
prices do not reflect scarcity, but rather the high cost of 
manufacture. 
There is a great need for an inexpensive source of 
carotenoids to promote human health, such as the treatment 
of hives and other dermatoses, and prevent certain types of 
eye disorders, such as macular degeneration. 
SUMMARY OF THE INVENTION 
This summary of invention section is intended to intro- 
duce the reader to aspects of the invention and is not a 
complete description of the invention. Particular aspects of 
the invention are pointed out in other sections hereinbelow, 
and the invention is set forth in the appended claims which 
alone demarcate its scope. 
The invention provides a unique method of preparing a 
carotenoid, zeaxanthin, through use of an alga. In particular, 
in one embodiment of the invention a Chlorophyta alga is 
cultured in a medium in the presence of light, and then 
harvested. The harvested cells are separated, for example, by 
centrifugation, and contain zeaxanthin and lutein, among 
other components, in a solid product. The carotenoids are 
present in a sufficient concentration in the solid for thera- 
peutic or prophylactic administration to humans, or may be 
further purified to increase carotenoid concentration. 
2 
BRIEF DESCRIPTION OF THE DRAWINGS 
The following drawings are illustrative of embodiments 
of the invention and therefore do not limit the scope of the 
invention, but are presented to assist in providing a proper 
understanding of the invention. The drawings are not to 
scale, and are intended for use in conjunction with the 
explanations in the following detailed description section. 
FIG. 1 is an output of a high pressure liquid chromato- 
graph of acetone extracted pigments recovered from a 
10 detergent-insoluble pellet, during an example in accordance 
with the invention; 
FIG. 2 is an EDAX analysis of the pellet of FIG. 1, 
showing the predominant inorganic component is phos- 
phate, with divalent calcium and magnesium cations; 
FIG. 3 is a NMR spectrum showing that the polyphos- 
phate is the predominant form of the inorganic phosphate. 
FIG. 4 is an SDS-PAGE of the detergent-insoluble pellet 
indicating that the major protein is a 70 kDa protein. 
15 
DETAILED DESCRIPTION OF THE 
INVENTION 
20 
This section describes aspects of the invention, and points 
out certain preferred embodiments of these aspects. This 
section is not intended to be exhaustive, but rather to inform 
25 and teach the person of skill in the art who will come to 
appreciate more fully other aspects, equivalents, and possi- 
bilities presented by the invention, and hence the scope of 
the invention as set forth in the claims which alone limit its 
scope. 
In accordance with an embodiment of the invention, a 
strain of Chlorophyta green algae is cultured under mild 
conditions in a minimal inorganic medium to produce cells 
that, upon harvesting, contain a relatively high concentration 
of carotenoids. The Chlorophyta algae may include the 
35 genus Chlamydomonas, Dunaliella, or any other suitable 
Chlorophyta algae. The medium may be formed of the 
following: 7.5 mM sodium acetate or sodium bicarbonate, 
1 .O mM sodium citrate, 3.0 mM K,PO,, 7.0 mM KH,PO,, 
7.5 mM NH,Cl, 0.1 mM CaCl,, 1.0 mM MgSO4, 0.01 mM 
FeCl, supplemented with 1 mlil trace metals in the concen- 
40 tration of(mg1100 ml) H,BO,, 100; ZnS0,.7H,O, 100; 
MnS0,.4H,O, 40; CoC1,.6H,O, 20; Na,Mo0,.2H,O, 20; 
CuSO,.SH,O, 6. This description of the medium is not to be 
limiting and it will be appreciated that any suitable medium 
for growing Chlorophyta may be used. The Chlorophyta 
45 algae cells are grown in a temperature range of from 
approximately 25” C. to about 35” C. for a period of 3 to 
about 14 days. A detergent-insoluble pellet, for example, a 
Triton-X 100-insoluble pellet, prepared from these cells 
contains most of the zeaxanthin. The detergent insoluble 
50 pellet containing the algae cells may be extracted by sus- 
pending the pellet in a phosphate buffer, a Tris-HCL solution 
or any suitable suspending medium containing 1 .O% (WIV) 
detergent, and sonicating and cetrifuging the mixture. The 
pellet may then be prepared for use as a nutritional supple- 
55 ment by, for example, drying it and/or encapsulating. Alter- 
natively, it may be subjected to heat to isolate the caro- 
tenoids. 
In this example approximately 2 pgimg of oxygenated 
carotenoid may be isolated with the pellet (granule) prepa- 
ration. This procedure could apply to any carotenoid 
6o selected by spontaneous or engineered mutation to be syn- 
thesized in Chlorophyta. For example, a strain producing 
only zeaxanthin would yield a granular product containing 
zeaxanthin as the sole oxygenated carotenoid. Some caro- 
tenoid mutations may generate light sensitive strains of 
65 algae; however, due to the flexibility of Chlorophyta to 
growth conditions, the strain may be grown in the dark as 
long as a suitable carbon source such as acetate or glucose 
30 
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is provided. Stress, such as nutrient depravation, may also 
stimulate synthesis and transfer of selected carotenoids to 
the granule. 
EXAMPLE 
Strain CC-373 (ac-u-c-2-21) used in this example was a 
gift from a stock maintained at the Chlamydomonas culture 
collection at Duke University, Durham, N.C. Cells grown in 
a minimal inorganic medium at 25" C. in the light for 3 to 
4 days (late log to stationary phase) were harvested by 
centrifugation at 1000 g. The medium was formed of the 
following: 7.5 mM sodium acetate, 1 .O mM sodium citrate, 
3.0 mM K,PO,, 7.0 mM KH,PO,, 7.5 mM NH,Cl, 0.1 mM 
CaCl,, 1 .O mM MgSO,, 0.01 mM FeCl, supplemented with 
1 mlil trace metals in the concentration of (mgi100 ml) 
H,BO,, 100; ZnS0,.7H,O, 100; MnS0,.4H,O, 40; 
CoC1,.6H,O, 20; Na,Mo0,.2H,O, 20; CuSO,.SH,O, 6. The 
pelleted cells were suspended in 50 mM phosphate buffer 
(pH 7.0) or 10 mM Tris-HC1 (PH 8.0) containing 1 .O% (wiv) 
Triton X-100, broken by sonication and centrifuged at 1000 
g for 5 min. The pellet was washed two times with 1.0% 
Triton X-100 in buffer (50 mM phosphate, pH 7.0) and then 
two times with buffer. The resulting pellet contains zeaxan- 
thin, lutein, polyphosphate, Ca", Mg2+, several proteins and 
starch (FIGS. 2-4). Oxygenated carotenoids can be liberated 
from the pellet fraction by a simple heating treatment. 
Analysis of carotenoid composition of Chlamydomonas 
reinhardtii CC-373 demonstrated that the strain was defi- 
cient in the epoxidated carotenoids neoxanthin (3S,5R,6R, 
3 3  5'R,6'S)-5',6'-epoxy-6,7-didehydro-5,6,5'6'-tetrahydro- 
fl,flcarotene-3,5,3'-triol), violaxanthin ((3S,5R,6S,3'S,5'R, 
6 ' S ) - 5 , 6 , 5 ' , 6 ' - d i e p o x y - 5 , 6 , 5 ' , 6 ' - t e t r a h y e - 3 , 3 ' -  
diol, and antheraxanthin ((3S,5R,6S,3'R)-5,6-epoxy-5,6- 
dihydro- fl,fl-carotene-3,3'-diol). In whole cells, the amount 
of zeaxanthin ((3R,3'R)-f13fl-carotene-3,3'-diol) was 
increased to a level greater than that of lutein ((3R,3'R,6'R)- 
fl,~-carotene-3,3'-diol). Upon analysis, only a relatively 
small amount of zeaxanthin was present in the membrane, 
which is traditionally considered its normal physiological 
domain. Rather, the bulk of zeaxanthin was recovered in a 
Triton X-100-insoluble pellet fraction (FIG. 1). The Triton 
X-100-insoluble fraction pelleted through 1.5 M sucrose, a 
characteristic of polyphosphate granules that form within 
cytoplasmic vacuoles. Electron micrographs suggest that the 
membrane of these vacuoles is derived from the chloroplast 
envelope. The formation of these dense cytoplasmic vacu- 
oles is not confined to Chlamydomonas but is thought to be 
common through Chlorophyta, i.e. Dunaliella, etc. The 
apparent transfer of zeaxanthin to chloroplast envelope- 
derived cytosolic vacuoles allows for the simple preparation 
of a zeaxanthin enriched product without the use of solvents. 
The foregoing description provides an enabling disclosure 
of the invention, which is not limited by the description, but 
only by the scope of the appended claims. All those other 
aspects of the invention, and their equivalents, that will 
become apparent when a person of skill in the art has read 
the foregoing, are within the scope of the invention and of 
the claims hereinbelow. 
I claim: 
1. A method of producing a carotenoid in a detergent- 
insoluble pellet purified from soluble cellular components 
comprising: 
culturing a strain of Chlorophyta algae cells in a minimal 
inorganic growth medium; 
separating said algae cells from said minimal inorganic 
growth medium to obtain harvested algae; 
treating said harvested algae with detergent to obtain a 
detergent-insoluble pellet fraction comprising a caro- 
tenoid and 
separating said detergent-insoluble pellet fraction from 
2. The method of claim 1, wherein said strain of Chlo- 
rophyta algae cells comprises a strain of Chlamydomonas 
cells. 
3. The method of claim 1, wherein the carotenoid is 
selected from zeaxanthin and lutein. 
4. A detergent-insoluble pellet form of carotenoid, the 
pellet form obtained from a process comprising: 
culturing a strain of Chlorophyta algae cells in a minimal 
inorganic growth medium; 
separating said algae cells from said minimal inorganic 
growth medium to obtain harvested algae; 
treating said harvested algae with detergent to obtain a 
detergent-insoluble pellet fraction comprising a caro- 
tenoid wherein liquid chromatography of said pellet 
fraction produces acetone extracted pigments, as shown 
in FIG. 1; and 
separating said detergent-insoluble pellet fraction from 
soluble cellular material. 
5. The detergent-insoluble pellet form of carotenoid of 
claim 4, wherein said strain of Chlorophyta algae cells 
comprises a strain of Chlamydomonas cells. 
6. The detergent-insoluble pellet form of carotenoid of 
claim 4, wherein the carotenoid is selected from zeaxanthin 
7. A detergent-insoluble pellet form of carotenoid, the 
culturing a strain of Chlorophyta algae cells in a minimal 
inorganic growth medium; 
separating said algae cells from said minimal inorganic 
growth medium to obtain harvested algae; 
treating said harvested algae with detergent to obtain a 
detergent-insoluble pellet fraction comprising a caro- 
tenoid wherein energy dispersive x-ray analysis of said 
pellet fraction, having the EDAX analysis as illustrated 
in FIG. 2, shows phosphate with divalent calcium and 
magnesium cations as a predominant inorganic com- 
ponent; and 
separating said detergent-insoluble pellet fraction from 
soluble cellular material. 
8. The detergent-insoluble pellet form of carotenoid of 
claim 7, wherein said strain of Chlorophyta algae cells 
comprises a strain of Chlamydomonas cells. 
9. The detergent-insoluble pellet form of carotenoid of 
claim 7, wherein the carotenoid is selected from zeaxanthin 
10. A detergent-insoluble pellet form of carotenoid, the 
culturing a strain of Chlorophyta algae cells in a minimal 
inorganic growth medium; 
separating said algae cells from said minimal inorganic 
growth medium to obtain harvested algae; 
treating said harvested algae with detergent to obtain a 
detergent-insoluble pellet fraction comprising a caro- 
tenoid wherein a sodium dodecyl (lauryl) sulfate- 
polyacrylamide gel electrophoresis of said pellet frac- 
tion indicates a 70 kDa protein as a major protein as 
illustrated in FIG. 4; and 
separating said detergent-insoluble pellet fraction from 
soluble cellular material. 
11. The detergent-insoluble pellet form of carotenoid of 
claim 10, wherein said strain of Chlorophyta algae cells 
comprises a strain of Chlamydomonas cells. 
12. The detergent-insoluble pellet form of carotenoid of 
claim 10, wherein the carotenoid is selected from zeaxanthin 
soluble cellular material. 
10 
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25 and lutein. 
pellet form obtained from a process comprising: 
30 
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45 and lutein. 
pellet form obtained from a process comprising: 
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65 and lutein. 
* * * * *  
